{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:51Z","timestamp":1792644051180,"version":"4.5.0"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["SZY-KJCYC-2025-ZY-002"],"award-info":[{"award-number":["SZY-KJCYC-2025-ZY-002"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-SLRH-YQ-009"],"award-info":[{"award-number":["2022-SLRH-YQ-009"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2025-CXTD-07"],"award-info":[{"award-number":["2025-CXTD-07"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009996","name":"Shaanxi Province Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025BSHSDZZ335"],"award-info":[{"award-number":["2025BSHSDZZ335"]}],"id":[{"id":"10.13039\/501100009996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373843"],"award-info":[{"award-number":["82373843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82607515"],"award-info":[{"award-number":["82607515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404584"],"award-info":[{"award-number":["82404584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["25JC022"],"award-info":[{"award-number":["25JC022"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["25JC015"],"award-info":[{"award-number":["25JC015"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["25JC019"],"award-info":[{"award-number":["25JC019"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["25JC006"],"award-info":[{"award-number":["25JC006"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["25JR042"],"award-info":[{"award-number":["25JR042"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025QCY-KXJ-102"],"award-info":[{"award-number":["2025QCY-KXJ-102"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026SF-YBXM-616"],"award-info":[{"award-number":["2026SF-YBXM-616"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025QY-GJHX-48"],"award-info":[{"award-number":["2025QY-GJHX-48"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026SF-YBXM-136"],"award-info":[{"award-number":["2026SF-YBXM-136"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024SF-ZDCYL-03-25"],"award-info":[{"award-number":["2024SF-ZDCYL-03-25"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024CY-JJQ-52"],"award-info":[{"award-number":["2024CY-JJQ-52"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026PT-KXJ-078"],"award-info":[{"award-number":["2026PT-KXJ-078"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026PT-KXJ-070"],"award-info":[{"award-number":["2026PT-KXJ-070"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024SF-GJHX-12"],"award-info":[{"award-number":["2024SF-GJHX-12"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025QCY-KXJ-107"],"award-info":[{"award-number":["2025QCY-KXJ-107"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024PT-ZCK-20"],"award-info":[{"award-number":["2024PT-ZCK-20"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024CY-JJQ-73"],"award-info":[{"award-number":["2024CY-JJQ-73"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026RC-KJXX-143"],"award-info":[{"award-number":["2026RC-KJXX-143"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008387","name":"Xi'an Science and Technology Bureau","doi-asserted-by":"publisher","award":["24XTHG0010"],"award-info":[{"award-number":["24XTHG0010"]}],"id":[{"id":"10.13039\/501100008387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008387","name":"Xi'an Science and Technology Bureau","doi-asserted-by":"publisher","award":["25KXGC00005"],"award-info":[{"award-number":["25KXGC00005"]}],"id":[{"id":"10.13039\/501100008387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008387","name":"Xi'an Science and Technology Bureau","doi-asserted-by":"publisher","award":["25ZDLJQ00018"],"award-info":[{"award-number":["25ZDLJQ00018"]}],"id":[{"id":"10.13039\/501100008387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119360","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:43:38Z","timestamp":1790135018000},"page":"119360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development"],"prefix":"10.1016","volume":"320","author":[{"given":"Bingxing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-8998","authenticated-orcid":false,"given":"Chengyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119360_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2026.119360_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119360_bib4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib5","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","volume":"112","author":"Garton","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119360_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104961","article-title":"Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments","volume":"144","author":"Rehman","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib8","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.3390\/ijms24043380","article-title":"Aggregation of disordered proteins associated with neurodegeneration","volume":"24","author":"Tsoi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib9","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.3390\/ijms26115177","article-title":"The role of inflammation in neurodegenerative diseases: parkinson's disease, Alzheimer's disease, and multiple sclerosis","volume":"26","author":"Folta","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib12","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","article-title":"Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity","volume":"12","author":"Bido","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119360_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arr.2016.08.008","article-title":"ER stress and impaired autophagy flux in neuronal degeneration and brain injury","volume":"34","author":"Yin","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.443","article-title":"Continued 26S proteasome dysfunction in mouse brain cortical neurons impairs autophagy and the Keap1-Nrf2 oxidative defence pathway","volume":"8","author":"Ugun-Klusek","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/pharmaceutics16060708","article-title":"Drug development for Alzheimer's and Parkinson's disease: where do we go now?","volume":"16","author":"Sequeira","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119360_bib16","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/ijms24032513","article-title":"Cannabinoids in the modulation of oxidative signaling","volume":"24","author":"Pagano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nm.4311","article-title":"A chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice","volume":"23","author":"Bilkei-Gorzo","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102386","article-title":"Cannabidiol and neurodegeneration: from molecular mechanisms to clinical benefits","volume":"100","author":"Jha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and therapeutic properties of cannabidiol for epilepsy","volume":"79","author":"Franco","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2026.119360_bib22","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","article-title":"The essential medicinal chemistry of cannabidiol (CBD)","volume":"63","author":"Nelson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib23","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.3390\/ijms22094876","article-title":"The (poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: molecular mechanisms and targets","volume":"22","author":"Vitale","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib24","article-title":"The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectives","volume":"227","author":"Baldasso","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2017.00422","article-title":"An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2026.119360_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13195-020-00688-1","article-title":"Microglia prevent \u03b2-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance","volume":"12","author":"Feng","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejmech.2026.119360_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejmech.2026.119360_bib29","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","article-title":"APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF\u03b2-mediated checkpoints","volume":"24","author":"Yin","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2026.119360_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119360_bib32","article-title":"Neurotoxic microglial activation via IFN\u03b3-induced Nrf2 reduction exacerbating Alzheimer's disease","volume":"11","author":"Kang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer's disease","volume":"12","author":"Valiukas","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib34","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.3390\/ijms26104592","article-title":"Amyloid \u03b2-induced inflammarafts in Alzheimer's disease","volume":"26","author":"Ding","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41419-022-04758-0","article-title":"AGE-TXNIP axis drives inflammation in Alzheimer's by targeting A\u03b2 to mitochondria in microglia","volume":"13","author":"Sbai","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib36","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-020-00787-5","article-title":"Inhibitors of src family kinases, inducible nitric oxide synthase, and NADPH oxidase as potential CNS drug targets for neurological diseases","volume":"35","author":"Gage","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2026.119360_bib38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/bph.13425","article-title":"NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease","volume":"174","author":"Haslund-Vinding","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib39","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/bph.13426","article-title":"Microglia antioxidant systems and redox signalling","volume":"174","author":"Vilhardt","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib40","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1046\/j.1460-9568.2003.02663.x","article-title":"Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro","volume":"17","author":"Boucsein","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbi.2015.06.020","article-title":"Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor","volume":"50","author":"Xu","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2026.119360_bib42","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.3390\/jcm13237243","article-title":"Alpha-Synuclein and microglia in Parkinson's disease: from pathogenesis to therapeutic prospects","volume":"13","author":"Eo","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib43","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/glia.24385","article-title":"Microglia-specific knock-out of NF-\u03baB\/IKK2 increases the accumulation of misfolded \u03b1-synuclein through the inhibition of p62\/sequestosome-1-dependent autophagy in the rotenone model of Parkinson's disease","volume":"71","author":"Rocha","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2026.119360_bib44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/glia.23970","article-title":"\u03b1-Synuclein evokes NLRP3 inflammasome-mediated IL-1\u03b2 secretion from primary human microglia","volume":"69","author":"Pike","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2026.119360_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-Synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in Parkinson's disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejmech.2026.119360_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103970","article-title":"Human tau accumulation promotes glycogen synthase kinase-3\u03b2 acetylation and thus upregulates the kinase: a vicious cycle in Alzheimer neurodegeneration","volume":"78","author":"Zhou","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2026.119360_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","article-title":"Amyloid activates GSK-3\u03b2 to aggravate neuronal tauopathy in bigenic mice","volume":"172","author":"Terwel","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2026.119360_bib50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer's disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dionisio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","article-title":"Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization","volume":"14","author":"Lurette","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib53","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, tau, and \u03b1-synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.119360_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","article-title":"Autophagy, aging, and age-related neurodegeneration","volume":"113","author":"Palmer","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119360_bib56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119360_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer's diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2026.119360_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2026.119360_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","article-title":"Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: emerging mechanisms","volume":"91","author":"Benarroch","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2026.119360_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41573-024-00958-9","article-title":"Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition","volume":"23","author":"Kenakin","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119360_bib62","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib63","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48792","article-title":"Molecular mechanism of TRPV2 channel modulation by cannabidiol","volume":"8","author":"Pumroy","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119360_bib64","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/bph.12615","article-title":"Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation","volume":"171","author":"Hassan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib65","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.3390\/ijms23105367","article-title":"Cannabidiol enhances microglial Beta-amyloid peptide phagocytosis and clearance via vanilloid family type 2 channel activation","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib66","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib68","first-page":"17","article-title":"The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation","volume":"8","author":"Bow","year":"2016","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib69","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1021\/acs.jnatprod.9b01284","article-title":"The oxidation of phytocannabinoids to cannabinoquinoids","volume":"83","author":"Caprioglio","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119360_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/dmd.120.000350","article-title":"Cytochrome P450-catalyzed metabolism of cannabidiol to the active metabolite 7-hydroxy-cannabidiol","volume":"49","author":"Beers","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2026.119360_bib71","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2026.119360_bib72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/acsmedchemlett.3c00461","article-title":"Cannabidiol-based prodrugs: synthesis and bioevaluation","volume":"15","author":"Singh Cham","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119360_bib73","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1089\/can.2023.0025","article-title":"Pharmacokinetics of cannabidiol: a systematic review and meta-regression analysis","volume":"9","author":"Moazen-Zadeh","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112163","article-title":"Overview of cannabidiol (CBD) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease","volume":"192","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113735","article-title":"Novel cannabidiol\u2212carbamate hybrids as selective BuChE inhibitors: docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease","volume":"223","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib76","article-title":"Structure\u2013tissue exposure\/selectivity relationship (STR) on carbamates of cannabidiol","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib77","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/acs.bioconjchem.5c00012","article-title":"Mitigating cannabidiol's non-selective cytotoxicity via subcellular organelle targeting: exploring mitochondrial targeting potential","volume":"36","author":"Liu","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib78","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1021\/acs.jmedchem.3c00061","article-title":"Structure\u2013activity relationship study of cannabidiol-based analogs as negative allosteric modulators of the \u03bc-opioid receptor","volume":"66","author":"Bosquez-Berger","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phytol.2022.08.004","article-title":"New cannabidiol (CBD) derivatives: synthesis, anti-inflammatory activity, and molecular docking","volume":"51","author":"Zi","year":"2022","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.ejmech.2026.119360_bib80","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1021\/acs.jmedchem.2c01988","article-title":"Novel synthesis of C-methylated phytocannabinoids bearing anti-inflammatory properties","volume":"66","author":"Lavi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib81","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/molecules30061291","article-title":"Cannabidiol-based thiosemicarbazones: a preliminary study evaluating their anti-tyrosinase properties","volume":"30","author":"Peretz","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119360_bib82","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1021\/acs.jmedchem.3c01029","article-title":"Cannabidiol analogue CIAC001 for the treatment of morphine-induced addiction by targeting PKM2","volume":"66","author":"Jin","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117262","article-title":"Chiral recognition of CIAC001 isomers in regulating pyruvate kinase M2 and mitigating neuroinflammation","volume":"285","author":"Jin","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib84","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s12031-022-02038-2","article-title":"Anti-inflammatory properties of KLS-13019: a novel GPR55 antagonist for dorsal root ganglion and hippocampal cultures","volume":"72","author":"Brenneman","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116048","article-title":"Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety","volume":"265","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib86","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119360_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105439","article-title":"Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: effects on mood, cognitive implications, and synaptic signaling","volume":"155","author":"Stachowicz","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109329","article-title":"Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum","volume":"223","author":"Ferre","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","article-title":"Synaptic functions of endocannabinoid signaling in health and disease","volume":"124","author":"Araque","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105226","article-title":"CB2 receptor in the CNS: from immune and neuronal modulation to behavior","volume":"150","author":"Grabon","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib91","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/ijms21041295","article-title":"Chronic cannabidiol administration fails to diminish blood pressure in rats with primary and secondary hypertension despite its effects on cardiac and plasma endocannabinoid system, oxidative stress and lipid metabolism","volume":"21","author":"Remiszewski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuropharm.2004.02.017","article-title":"Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids","volume":"47","author":"Breivogel","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib93","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjp.0707252","article-title":"Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus","volume":"151","author":"Kofalvi","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib94","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5-HT1A and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib95","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)63558-4","article-title":"Neuroprotective effect of (\u2212)\u03949-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite","volume":"163","author":"El-Remessy","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2026.119360_bib96","doi-asserted-by":"crossref","first-page":"P5.5","DOI":"10.1212\/WNL.92.15_supplement.P5.5-007","article-title":"The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007)","volume":"92","author":"Nichol","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2026.119360_bib97","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.3390\/ijms22168920","article-title":"Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson's disease","volume":"22","author":"Giuliano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib98","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijms19113543","article-title":"Inhibition of microglia-derived oxidative stress by ciliary neurotrophic factor protects dopamine neurons in vivo from MPP+ neurotoxicity","volume":"19","author":"Baek","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib99","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2026.119360_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119360_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108736","article-title":"Mechanisms of endocannabinoid control of synaptic plasticity","volume":"197","author":"Winters","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib102","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119360_bib103","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib104","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib105","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","volume":"13","author":"Anand","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175205","article-title":"Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease","volume":"134","author":"Moe","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119360_bib107","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/glia.24489","article-title":"The two synthetic cannabinoid compounds 4'-F-CBD and HU-910 efficiently restrain inflammatory responses of brain microglia and astrocytes","volume":"72","author":"Dos Santos Pereira","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2026.119360_bib108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbi.2023.05.008","article-title":"Cannabidiol alleviates neuroinflammation and attenuates neuropathic pain via targeting FKBP5","volume":"111","author":"Wang","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2026.119360_bib109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2026.119360_bib110","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/ptr.7458","article-title":"Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-\u03baB-mediated signaling","volume":"36","author":"Borgonetti","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib111","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib112","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-10-16","article-title":"Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia","volume":"10","author":"Gomes","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119360_bib114","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1570159X16666180828100002","article-title":"Current progress on peroxisome proliferator-activated receptor \u03b3 agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: an update","volume":"17","author":"Khan","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","article-title":"PPAR agonists for the treatment of neuroinflammatory diseases","volume":"45","author":"Titus","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119360_bib117","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","article-title":"Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease","volume":"9","author":"de la Monte","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib118","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","article-title":"A multi-center randomized proof-of-concept clinical trial applying [18F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease","volume":"22","author":"Tzimopoulou","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib119","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-201610","article-title":"A precision medicine approach to treating Alzheimer's disease using rosiglitazone therapy: a biomarker analysis of the REFLECT trials","volume":"81","author":"O'Bryant","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-018-1103-y","article-title":"Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy","volume":"15","author":"Navarrete","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119360_bib121","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-022-02540-9","article-title":"A cannabidiol aminoquinone derivative activates the PP2A\/B55\u03b1\/HIF pathway and shows protective effects in a murine model of traumatic brain injury","volume":"19","author":"Navarrete","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119360_bib122","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119360_bib123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets \u2014 what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119360_bib124","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119360_bib125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41421-022-00388-0","article-title":"PPAR\u03b3 phase separates with RXR\u03b1 at PPREs to regulate target gene expression","volume":"8","author":"Li","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.ejmech.2026.119360_bib126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells","volume":"10","author":"Glass","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119360_bib127","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1038\/s41467-024-51884-8","article-title":"Cannabidiol ameliorates mitochondrial disease via PPAR\u03b3 activation in preclinical models","volume":"15","author":"Puighermanal","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119360_bib128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119360_bib129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119360_bib130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119360_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/ars.2017.7144","article-title":"Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation","volume":"29","author":"Paloczi","year":"2018","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejmech.2026.119360_bib132","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.18632\/aging.202951","article-title":"Potential role of cannabidiol in Parkinson's disease by targeting the WNT\/\u03b2-catenin pathway, oxidative stress and inflammation","volume":"13","author":"Vallee","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejmech.2026.119360_bib133","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/ijms21176235","article-title":"Distinctive evidence involved in the role of endocannabinoid signalling in Parkinson's disease: a perspective on associated therapeutic interventions","volume":"21","author":"Behl","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib134","doi-asserted-by":"crossref","first-page":"46603","DOI":"10.18632\/oncotarget.10314","article-title":"Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis","volume":"7","author":"Zeissler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.119360_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118624","article-title":"Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP\/PS1 Alzheimer's mice uncovered by RNA-seq","volume":"264","author":"Hao","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107705","article-title":"PPAR\u03b3\/PGC1\u03b1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders","volume":"219","author":"Jamwal","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119360_bib137","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.3390\/ijms24055055","article-title":"Cannabidiol as a promising therapeutic option in IC\/BPS: in vitro evaluation of its protective effects against inflammation and oxidative stress","volume":"24","author":"Kuret","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116742","article-title":"CBD and the 5-HT1A receptor: a medicinal and pharmacological review","volume":"233","author":"Alexander","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib139","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0707464","article-title":"GPR55: a new member of the cannabinoid receptor clan?","volume":"152","author":"Pertwee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.neuron.2023.01.018","article-title":"Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity","volume":"111","author":"Rosenberg","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.119360_bib141","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib142","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1111\/bph.15842","article-title":"Inhibition of human recombinant T-type calcium channels by phytocannabinoids in vitro","volume":"179","author":"Mirlohi","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib143","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/bph.16035","article-title":"Differential regulation of Cav3.2 and Cav2.2 calcium channels by CB1 receptors and cannabidiol","volume":"180","author":"Harding","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib144","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/brain\/aww129","article-title":"Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol","volume":"139","author":"Patel","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2026.119360_bib145","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Nav channels through two distinct binding sites","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119360_bib146","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.119360_bib147","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits \u03b2-amyloid-induced tau protein hyperphosphorylation through WNT\/\u03b2-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109371","article-title":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of toll-like type-4(toll-like 4) receptors and NF-\u03baB signaling","volume":"133","author":"Majdi","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejmech.2026.119360_bib149","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/glia.23738","article-title":"Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS\/NF-\u03baB-dependent signaling and glucose consumption","volume":"68","author":"Dos-Santos-Pereira","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2026.119360_bib150","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of \u03b2 amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib151","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Martin-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib152","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms18010026","article-title":"Cannabidiol modulates the expression of Alzheimer's disease-related genes in mesenchymal stem cells","volume":"18","author":"Libro","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2013.11.016","article-title":"Increase of mesenchymal stem cell migration by cannabidiol via activation of p42\/44 MAPK","volume":"87","author":"Schmuhl","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib154","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2026.119360_bib155","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib156","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-191242","article-title":"Chronic treatment with 50 mg\/kg cannabidiol improves cognition and moderately reduces A\u03b240 levels in 12-month-old male A\u03b2PPswe\/PS1\u0394E9 transgenic mice","volume":"74","author":"Watt","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib157","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APPswe\/PS1\u0394E9 transgenic female mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/alz.054009","article-title":"Effects of cannabidiol (CBD) treatment in a mouse model of Alzheimer's disease through regulation of interleukin-5","volume":"17","author":"Khodadadi","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejmech.2026.119360_bib160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/ijms23031076","article-title":"Cannabidiol treatment improves glucose metabolism and memory in streptozotocin-induced Alzheimer's disease rat model: a proof-of-concept study","volume":"23","author":"de Paula Faria","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172970","article-title":"Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58\/2 transgenic mice","volume":"196","author":"Watt","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2026.119360_bib162","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11064-018-2513-z","article-title":"Cannabidiol reverses deficits in hippocampal LTP in a model of Alzheimer's disease","volume":"44","author":"Hughes","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib163","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.phymed.2012.04.002","article-title":"Effects of cannabinoids \u03949-tetrahydrocannabinol, \u03949-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures","volume":"19","author":"Moldzio","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.119360_bib164","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/biom14050564","article-title":"Protective effects of cannabidiol (CBD) against qxidative stress, but not excitotoxic-related neuronal cell damage-an in vitro study","volume":"14","author":"Jantas","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119360_bib165","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib166","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tiv.2015.11.004","article-title":"The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease","volume":"30","author":"Santos","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2026.119360_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104553","article-title":"Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT\/mTOR pathway","volume":"143","author":"Gugliandolo","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2026.119360_bib168","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/antiox9020135","article-title":"Cannabidiol protects dopaminergic neurons in mesencephalic cultures against the complex I inhibitor rotenone via modulation of heme oxygenase activity and bilirubin","volume":"9","author":"Duvigneau","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.119360_bib169","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/acschemneuro.3c00176","article-title":"Cannabidiol protects dopaminergic-like neurons against paraquat- and maneb-induced cell death through safeguarding DJ-1CYS106 and caspase 3 independently of cannabinoid receptors: relevance in Parkinson's disease","volume":"14","author":"Mendivil-Perez","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.654340","article-title":"Cannabidiol induces autophagy to protects neural cells from mitochondrial dysfunction by upregulating SIRT1 to inhibits NF-\u03baB and NOTCH pathways","volume":"15","author":"Kang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.945836","article-title":"Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats","volume":"13","author":"Patricio","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1539783","article-title":"Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism","volume":"16","author":"Lima","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib173","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2016.00343","article-title":"Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats","volume":"7","author":"Peres","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib174","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib175","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson's disease","volume":"163","author":"Garcia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib176","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107808","article-title":"Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease","volume":"163","author":"Crivelaro do Nascimento","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib178","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","article-title":"Cannabidiol alleviates the damage to dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mice via regulating neuronal apoptosis and neuroinflammation","volume":"498","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2026.119360_bib179","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/ijms18040684","article-title":"Effects of a Sativex-like combination of phytocannabinoids on disease progression in R6\/2 mice, an experimental model of Huntington's disease","volume":"18","author":"Valdeolivas","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/14660820510030149","article-title":"Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival","volume":"6","author":"Weydt","year":"2005","journal-title":"Amyotroph Lateral Scler."},{"key":"10.1016\/j.ejmech.2026.119360_bib181","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/cns.12262","article-title":"Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1G93A transgenic mice and evaluation of a sativex\u00ae-like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis","volume":"20","author":"Moreno-Martet","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2026.119360_bib182","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2174\/138161208785740081","article-title":"The endocannabinoid system in amyotrophic lateral sclerosis","volume":"14","author":"Bilsland","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.119360_bib183","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00213-025-06785-z","article-title":"Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93A (SOD1G93A) mouse model of amyotrophic lateral sclerosis","volume":"242","author":"Ghimire","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2026.119360_bib184","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12974-015-0273-0","article-title":"Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells","volume":"12","author":"Kozela","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2026.119360_bib186","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42238-024-00238-8","article-title":"Non-linear plasma protein binding of cannabidiol","volume":"6","author":"Babayeva","year":"2024","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib187","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.drudis.2011.12.020","article-title":"Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival","volume":"17","author":"Morgan","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119360_bib188","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-025-01165-w","article-title":"Biomarker-guided decision making in clinical drug development for neurodegenerative disorders","volume":"24","author":"Cummings","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119360_bib189","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/d41573-024-00017-3","article-title":"Open science in precision medicine for neurodegenerative diseases","volume":"23","author":"Leonard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119360_bib190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s40290-022-00447-7","article-title":"The characteristics of clinical trials on cannabis and cannabinoids: a review of trials for therapeutic or drug development purposes","volume":"36","author":"Modaresi","year":"2022","journal-title":"Pharm. Med. (Lond.)"},{"key":"10.1016\/j.ejmech.2026.119360_bib191","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40290-025-00591-w","article-title":"Studies of cannabinoid-based products in ClinicalTrials.gov: a scoping review","volume":"40","author":"Haney","year":"2026","journal-title":"Pharm. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib192","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40290-022-00446-8","article-title":"The effectiveness and safety of cannabidiol in non-seizure-related indications: a systematic review of published randomized clinical trials","volume":"36","author":"Tang","year":"2022","journal-title":"Pharm. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib194","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib195","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox\u2013gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib198","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119360_bib207","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119360_bib197","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"Add-on cannabidiol treatment for drug-resistant seizures in Tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib199","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106933","article-title":"Use of cannabidiol (CBD) oil in the treatment of PTSD: study design and rationale for a placebo-controlled randomized clinical trial","volume":"122","author":"Telch","year":"2022","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.ejmech.2026.119360_bib209","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/life14111373","article-title":"The impact of cannabidiol treatment on anxiety disorders: a systematic review of randomized controlled clinical trials","volume":"14","author":"Coelho","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2026.119360_bib210","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial","volume":"46","author":"Silva","year":"2024","journal-title":"Trends Psychiatry Psychother"},{"key":"10.1016\/j.ejmech.2026.119360_bib196","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with lennox-gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119360_bib200","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119360_bib201","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: a proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Mol. Autism"},{"key":"10.1016\/j.ejmech.2026.119360_bib202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejmech.2026.119360_bib203","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug\u2013drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmech.2026.119360_bib204","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cpdd.665","article-title":"A phase 1, open-label, pharmacokinetic trial to investigate possible drug-drug interactions between clobazam, stiripentol, or valproate and cannabidiol in healthy subjects","volume":"8","author":"Morrison","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejmech.2026.119360_bib205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1159\/000521214","article-title":"Polypharmacy and hyperpolypharmacy in older individuals with parkinson's disease: a systematic review and meta-analysis","volume":"68","author":"Bhagavathula","year":"2022","journal-title":"Gerontology"},{"key":"10.1016\/j.ejmech.2026.119360_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1221069","article-title":"Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib211","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib212","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119360_bib213","article-title":"A study of tolerability and efficacy of cannabidiol on motor symptoms in Parkinson's disease","year":"2024","journal-title":"NCT03582137"},{"key":"10.1016\/j.ejmech.2026.119360_bib214","article-title":"A study of tolerability and efficacy of cannabidiol on tremor in Parkinson's disease","year":"2019","journal-title":"NCT02818777"},{"key":"10.1016\/j.ejmech.2026.119360_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.951889","article-title":"Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: a placebo controlled randomized clinical trial","volume":"9","author":"Hermush","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib216","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000541364","article-title":"Treatment of neuropsychiatric symptoms in Alzheimer's disease with a Cannabis-based magistral formulation: an open-label prospective cohort study","volume":"7","author":"Navarro","year":"2024","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.ejmech.2026.119360_bib224","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/00207454.2018.1481066","article-title":"Sativex\u00ae as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial","volume":"129","author":"Markova","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib217","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","article-title":"Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Riva","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in huntington's disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2026.119360_bib221","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib218","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(\u00ae)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib219","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/00207454.2020.1730832","article-title":"Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial","volume":"130","author":"Meuth","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119360_bib222","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2026.119360_bib223","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/pharmaceutics14122598","article-title":"Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020-2022)","volume":"14","author":"Souza","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119360_bib225","first-page":"238","article-title":"Metabolism and liver toxicity of cannabidiol","volume":"42","author":"Chen","year":"2024","journal-title":"J. Environ. Sci. Health C Toxicol. Carcinog."},{"key":"10.1016\/j.ejmech.2026.119360_bib226","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1021\/acs.jmedchem.4c03115","article-title":"Target engagement assays in early drug discovery","volume":"68","author":"St John-Campbell","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119360_bib227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2024.12.005","article-title":"Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders","volume":"46","author":"Manzoni","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib228","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/cpt.2973","article-title":"Evaluation of cytochrome P450-mediated cannabinoid-drug interactions in healthy adult participants","volume":"114","author":"Bansal","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119360_bib229","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/dta.407","article-title":"Cannabis - from cultivar to chemovar","volume":"4","author":"Hazekamp","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ejmech.2026.119360_bib230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/can.2016.0020","article-title":"Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography\/photodiode array-mass spectrometry","volume":"1","author":"Wang","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib231","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/plants10030566","article-title":"Different Cannabis sativa extraction methods result in different biological activities against a colon cancer cell line and healthy colon cells","volume":"10","author":"Rozanc","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.ejmech.2026.119360_bib232","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1039\/D2NP00059H","article-title":"Extraction techniques for bioactive compounds of cannabis","volume":"40","author":"Sainz Martinez","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.119360_bib233","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42238-022-00130-3","article-title":"An assessment of solvent residue contaminants related to cannabis-based products in the south african market","volume":"4","author":"Viviers","year":"2022","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib234","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42238-021-00087-9","article-title":"Processing and extraction methods of medicinal cannabis: a narrative review","volume":"3","author":"Lazarjani","year":"2021","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/can.2018.0014","article-title":"The anti-inflammatory properties of terpenoids from Cannabis","volume":"3","author":"Gallily","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejmech.2026.119360_bib236","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119360_bib237","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13812","article-title":"Evaluation of potential drug-drug interactions with medical cannabis","volume":"17","author":"Ho","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib238","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s11606-020-06504-8","article-title":"Cannabidiol interactions with medications, illicit substances, and alcohol: a comprehensive review","volume":"36","author":"Balachandran","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ejmech.2026.119360_bib239","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15026-z","article-title":"Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation","volume":"7","author":"Zgair","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119360_bib240","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s40262-020-00931-w","article-title":"The interplay between liver first-pass effect and lymphatic absorption of cannabidiol and its implications for cannabidiol oral formulations","volume":"59","author":"Franco","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.119360_bib241","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejpb.2020.06.021","article-title":"Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers","volume":"154","author":"Izgelov","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2026.119360_bib242","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10928-013-9306-4","article-title":"Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications","volume":"40","author":"Shannon","year":"2013","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejmech.2026.119360_bib243","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/138920008783331077","article-title":"CSF as a surrogate for assessing CNS exposure: an industrial perspective","volume":"9","author":"Lin","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2026.119360_bib244","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2133\/dmpk.DMPK-14-RG-026","article-title":"Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates","volume":"29","author":"Nagaya","year":"2014","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.119360_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.153016","article-title":"Cannabidiol selectively modulates interleukin (IL)-1\u03b2 and IL-6 production in toll-like receptor activated human peripheral blood monocytes","volume":"464","author":"Sermet","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2026.119360_bib246","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200080","article-title":"Cannabidiol modulation of oxidative stress and signalling","volume":"5","author":"Pereira","year":"2021","journal-title":"Neuronal Signaling"},{"key":"10.1016\/j.ejmech.2026.119360_bib247","doi-asserted-by":"crossref","first-page":"14412","DOI":"10.1021\/acsomega.2c00588","article-title":"The 18-kDa translocator protein PET tracers as a diagnostic marker for neuroinflammation: development and current standing","volume":"7","author":"Singh","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119360_bib248","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41380-024-02656-9","article-title":"PET imaging of neuroinflammation: any credible alternatives to TSPO yet?","volume":"30","author":"Chauveau","year":"2025","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2026.119360_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105698","article-title":"Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain","volume":"159","author":"Matarazzo","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119360_bib250","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1021\/acs.molpharmaceut.5c00452","article-title":"Cannabidiol-loaded nanostructured lipid carriers for nose to brain delivery: an effective therapeutic approach against epilepsy","volume":"22","author":"Wang","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119360_bib251","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/pharmaceutics13030412","article-title":"Stability study of cannabidiol in the form of solid powder and sunflower oil solution","volume":"13","author":"Kosovic","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119360_bib252","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41531-025-01125-6","article-title":"Balancing practicality and complexity in neuroimaging models of Parkinson's disease progression","volume":"11","author":"Kaasinen","year":"2025","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejmech.2026.119360_bib253","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1098454","article-title":"Study design challenges and strategies in clinical trials for rare diseases: lessons learned from pantothenate kinase-associated neurodegeneration","volume":"14","author":"Videnovic","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejmech.2026.119360_bib254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000535726","article-title":"Pharmacokinetic variability of oral cannabidiol and its major metabolites after short-term high-dose exposure in healthy subjects","volume":"7","author":"Zhang","year":"2024","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.ejmech.2026.119360_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105322","article-title":"Insights into the use of biomarkers in clinical trials in Alzheimer's disease","volume":"108","author":"Pascoal","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2026.119360_bib256","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/psp4.12015","article-title":"Establishing good practices for exposure-response analysis of clinical endpoints in drug development","volume":"4","author":"Overgaard","year":"2015","journal-title":"CPT Pharmacometrics Syst. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:22:10Z","timestamp":1792642930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":255,"alternative-id":["S0223523426008056"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119360","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119360"}}